CTLA4 and nonpapillary renal cell carcinoma: By using mRNA to analyze the methylation gene, PD‐L1 expression, and CD8+ T cell infiltration of patients, it was shown that hypomethylation of the CTLA‐4 promoter showed to be a strong biomarker for poor prognosis in patients with ccRCC at initial diagnosis.